Today: 18 November 2025
Subscribe
Browse Category

IPO News 9 October 2025 - 17 November 2025

Record Highs, $55 B Deals & Data Drama: Wall Street’s Wild Week (Oct 4–5, 2025)

IPO Week Nov 17–21, 2025: Excelsoft & Gallard Steel to open on Nov 19; PhysicsWallah, Emmvee, Tenneco, Fujiyama & Capillary set to list

Dateline: Monday, November 17, 2025 India’s primary market enters a quieter stretch this week, but action isn’t absent. Only two fresh IPOs—Excelsoft Technologies (mainboard) and Gallard Steel (SME)—will open for subscription on Wednesday, November 19, while seven companies are slated to list between Tuesday and Friday, keeping traders focused on debut-day price discovery. Moneycontrol Quick highlights for today What opens for subscription this week (Nov 19–21) Excelsoft Technologies IPO (Mainboard) Gallard Steel IPO (BSE SME) IPO listings to watch this week Grey market check (informal): Over the weekend, observers indicated the steepest premium in the unofficial market for Tenneco (25%+),
17 November 2025
 ·  ·  ·  ·  · 
Fujiyama Power Systems IPO Day 3 (Nov 17): Subscription surges to ~2x as QIB bids spike; GMP at ₹0 — price band, lot size, key dates, broker views

Fujiyama Power Systems IPO Day 3 (Nov 17): Subscription surges to ~2x as QIB bids spike; GMP at ₹0 — price band, lot size, key dates, broker views

New Delhi, November 17, 2025 — On the final day of bidding for Fujiyama Power Systems’ ₹828‑crore IPO, demand accelerated sharply in the afternoon after a slow start. As of 3:54 pm IST, exchange data cited by Upstox showed the issue subscribed 2.01x overall, led by QIBs at ~5.15x, while retail and NII portions were ~0.78x and ~0.80x, respectively. Earlier through the day, multiple trackers had reported a far more muted run‑rate, underscoring a familiar late‑day surge from institutions. Meanwhile, the grey market premium (GMP) stays at ₹0, implying no unofficial listing premium over the upper end of the price
17 November 2025
 ·  ·  ·  · 
Tenneco Clean Air India IPO: GMP Nears ₹123 on 16 November, 60x Subscription Sets Up Big Listing on 19 November

Tenneco Clean Air India IPO: GMP Nears ₹123 on 16 November, 60x Subscription Sets Up Big Listing on 19 November

On Sunday, 16 November 2025, investor focus in India’s primary market is firmly on Tenneco Clean Air India Ltd, the auto-systems maker whose ₹3,600 crore IPO has turned into one of the biggest blockbusters of the quarter. With the issue subscribed nearly 59–62 times and the grey market premium (GMP) hovering around ₹123 per share, the street is now gearing up for allotment finalisation on Monday and listing on Wednesday, 19 November 2025. Upstox – Online Stock and Share Trading+2Business Standard+2 Below is a complete snapshot of where the IPO stands today, 16 November, and what investors should watch as
16 November 2025
 ·  ·  ·  ·  · 
Battle for the Final Frontier: Space Tourism Face-Off — Blue Origin vs SpaceX vs Virgin Galactic

How to Buy Blue Origin Stock in 2025: Pre‑IPO Investing, Ownership, and What Today’s New Glenn Breakthrough Means for You

Published: November 14, 2025 Blue Origin just pulled off its most important mission to date — and it’s no surprise that “how to buy Blue Origin stock” is spiking in search today. On November 13–14, 2025, Jeff Bezos’ space company launched its giant New Glenn rocket from Cape Canaveral, sending two NASA ESCAPADE spacecraft on their way to Mars and successfully landing the first‑stage booster on an ocean barge for the first time. Reuters+2DW News+2 This is New Glenn’s first NASA science mission and its first booster landing after an orbital launch — a milestone that puts Blue Origin in
14 November 2025
 ·  ·  ·  · 
Groww IPO Day 2: Fully Subscribed (1.47x); Retail 4.65x, GMP 11–15%; Nithin Kamath Says 20% of Applications Came via Zerodha — What Top Brokerages Recommend

Groww IPO Allotment Status Today (November 10, 2025): Check on NSE, BSE & MUFG Intime; Latest GMP ~₹4, Listing Likely on Nov 12

Updated: November 10, 2025 The share allotment for the ₹6,632.3 crore Groww IPO (Billionbrains Garage Ventures Ltd) is scheduled to be finalised today, Monday, November 10, 2025. Investors can verify their status on the NSE, BSE and MUFG Intime India registrar portals once the basis of allotment is processed. The issue—priced in the ₹95–₹100 band—was subscribed about 17.6x overall, setting up a closely watched listing later this week. Groww+1 Key Takeaways at a Glance How to Check Groww IPO Allotment Status You can check allotment on any of the following: 1) NSE (IPO bid details) 2) BSE (Application status) 3)
10 November 2025
 ·  ·  ·  · 
Lenskart IPO Frenzy: Sky-High Valuation Meets Surging Demand – Will Investors See Big Gains?

Lenskart IPO Frenzy: Sky-High Valuation Meets Surging Demand – Will Investors See Big Gains?

IPO Overview: Unicorn Eyewear Retailer Goes Public Lenskart Solutions’ IPO is one of India’s biggest new-age tech listings this year, riding a wave of IPO mania on Dalal Street. The company – an omnichannel eyewear unicorn – is raising ₹7,278 crore through a combination of new shares and sales by existing shareholders financialexpress.com. At the ₹382–402 per share price band, Lenskart would be valued around ₹69,500–70,000 crore (approximately $7.9–8.0 billion) reuters.com. This makes it among the largest IPOs of 2025 in India, in line with other big-ticket listings amid a record year for fundraising reuters.com. Issue structure: About ₹2,150 crore
3 November 2025
 ·  ·  ·  ·  ·  ·  · 
ALPS Group Inc Stock Explodes on Nasdaq Debut – Malaysian Biotech Unicorn Takes Off

ALPS Group Inc Stock Explodes on Nasdaq Debut – Malaysian Biotech Unicorn Takes Off

Sources: Company filings and press releases (Oct 31, 2025) otcmarkets.com globenewswire.com; Nasdaq/GlobeNewswire announcements otcmarkets.com nasdaq.com; Reuters (Jan 2024) reuters.com reuters.com; TechNode (Malaysia biotech news) technode.global technode.global; Boardroom Alpha analysis boardroomalpha.com; financial data aggregators (Finviz, StockAnalysis) finviz.com stockanalysis.com. (No independent analyst reports found; quotes from company and media are cited.)
1 November 2025
 ·  ·  ·  ·  · 
Navan’s $6.5B IPO Set for Takeoff – TravelTech Unicorn Aims High, But Will It Deliver?

Navan’s IPO Flop? TravelTech Stock Sinks 12% on Nasdaq Debut

Rocky Market Debut: Shares Slip 12% Navan’s first day as a public company was rocky. The stock debuted on Nasdaq under the ticker NAVN, immediately trading below its IPO price. Reuters reports Navan “started trading 12% below” the offering price, opening around $22 reuters.com. By midday on Oct 30 the stock was near $21.14, a ~15% drop from $25 investing.com. This initial slide wiped out tens of millions in paper value – the company’s fully diluted market cap dipped to about $5.9–6.7 billion reuters.com. Some insiders put a positive spin on the debut’s rough start. CEO Ariel Cohen remained upbeat,
30 October 2025
 ·  ·  ·  ·  · 
Tata Capital’s ₹15,500-Crore IPO Rocks 2025 Markets – Should You Bet on India’s Biggest Listing?

Tata Capital’s ₹15,500-Crore IPO Rocks 2025 Markets – Should You Bet on India’s Biggest Listing?

Tata Capital IPO Overview & What’s at Stake Tata Capital Ltd – the financial services flagship of the 155-year-old Tata Group – is making its stock market debut with one of India’s biggest IPOs ever. The ₹15,512 crore (~$1.7 billion) offering opened for public bidding on October 6 and runs till October 8 timesofindia.indiatimes.com. This IPO is the largest in India this year, surpassing all other 2025 listings and even putting the Indian IPO market on track for a record fundraising month ndtv.com ndtv.com. The shares are offered in a price band of ₹310 to ₹326. Retail investors must buy
14 October 2025
 ·  ·  ·  ·  ·  · 
Turn Therapeutics (TTRX) Skyrockets After Nasdaq Debut – Biotech Breakthrough or Hype?

Turn Therapeutics (TTRX) Skyrockets After Nasdaq Debut – Biotech Breakthrough or Hype?

Company Profile – Background & Leadership Turn Therapeutics, Inc. is a Westlake Village, CA-based biotech company founded in 2015 renaissancecapital.com. The company (formerly named Global Health Solutions, Inc.) officially rebranded to Turn Therapeutics in Sept 2025 ahead of its Nasdaq listing stockanalysis.com. Turn’s mission is to “turn the tides” in medicine by developing technologies that heal, not just manage, challenging traditional treatments benzinga.com. CEO Bradley Burnam (the founder) leads a lean operation “built on a shoestring, with an absolute disdain for waste,” as he emphasized during the Nasdaq bell-ringing ceremony benzinga.com. Burnam and his team bring a “patient-first” approach and a frugal business model to drug development, aiming
9 October 2025
 ·  ·  ·  ·  · 
MedTech Giant’s IPO Shakes Up Market: Ottobock’s Blockbuster Debut Revives IPO Hopes

MedTech Giant’s IPO Shakes Up Market: Ottobock’s Blockbuster Debut Revives IPO Hopes

Ottobock’s Blockbuster Debut in Frankfurt Ottobock’s IPO made headlines as the prosthetics manufacturer delivered a much-needed jolt to Germany’s capital market. Trading in Ottobock shares began on October 9, 2025, on the Frankfurt Stock Exchange’s Prime Standard segment. The stock’s first trade at €72.00 was significantly above the €66 per share offering price deutsche-boerse.com. That opening price equated to about a +9% “pop” for IPO investors, underscoring the high demand for the shares. In fact, Ottobock’s debut is being celebrated as “the country’s largest IPO in over a year”, according to Reuters globalbankingandfinance.com. It’s a standout given the recent scarcity of large offerings in Frankfurt. The initial
9 October 2025
 ·  ·  ·  · 
1 2
Go toTop